Observational studyBMC ophthalmology2017

Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD.

Maria Waizel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.